Patent details
EP2283897 Title: HSA-free formulations of interferon-beta
Basic Information
- Publication number:
- EP2283897
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101806586
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HSA-free formulations of interferon-beta
- French Title of Invention:
- Formulation d'interférone beta ne contenant pas de HSA
- German Title of Invention:
- HSA-frei Interferon-Beta Formulierungen
- SPC Number:
Dates
- Filing date:
- 26/10/2001
- Grant date:
- 26/02/2014
- EP Publication Date:
- 26/02/2014
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/02/2011
- EP B1 Publication Date:
- 26/02/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/10/2014
- Expiration date:
- 26/10/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/10/2001
- Name:
- Novartis Vaccines and Diagnostics, Inc.
- Address:
- 4560 Horton Street, Emeryville, CA 94608, United States (US)
Inventor
1
- Name:
- Babuka Susan
- Address:
- United States (US)
2
- Name:
- Tellers Melanie
- Address:
- United States (US)
3
- Name:
- Shirley Bret
- Address:
- United States (US)
4
- Name:
- Choe Minna
- Address:
- United States (US)
Priority
1
- Priority Number:
- 282614 P
- Priority Date:
- 09/04/2001
- Priority Country:
- United States (US)
2
- Priority Number:
- 330404 P
- Priority Date:
- 18/10/2001
- Priority Country:
- United States (US)
3
- Priority Number:
- 35397
- Priority Date:
- 25/10/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61P 25/00;
| Filing date | Document type | Number of pages |
|---|